Evidence map›Paper›PMID 37495753›Full record

ReviewNature protocols2023

Large-scale growth of C. elegans and isolation of membrane protein complexes.

Sarah Clark, Hanbin Jeong, April Goehring, Yunsik Kang, Eric Gouaux

Open access · greenAbstract readReview
In one paragraph

Review in Nature protocols, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.7field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. The structure of theProceedings of the National Academy of Sciences of the United States of America · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Sarah ClarkVollum Institute, Oregon Health & Science University, Portland, OR, USA.
Hanbin JeongVollum Institute, Oregon Health & Science University, Portland, OR, USA.
April GoehringVollum Institute, Oregon Health & Science University, Portland, OR, USA.
Yunsik KangVollum Institute, Oregon Health & Science University, Portland, OR, USA.ORCID 0000-0002-5721-024X
Eric GouauxVollum Institute, Oregon Health & Science University, Portland, OR, USA. gouauxe@ohsu.edu.ORCID 0000-0002-8549-2360
Oregon Health & Science University · USHoward Hughes Medical Institute · US

Funding

Supplement for childcare costs for NRSA fellowF32DC017894 · NIDCD · OREGON HEALTH & SCIENCE UNIVERSITY · PI CLARK, SARAH A · 2019 to 2021
$196k
NIDCD NIH HHS F32 DC017894U.S. Department of Health & Human Services | NIH | National Institute on Deafness and Other Communication Disorders (NIDCD) 1F32DC017894
6 · The paper itself

Abstract

Purification of membrane proteins for biochemical and structural studies is commonly achieved by recombinant overexpression in heterologous cell lines. However, many membrane proteins do not form a functional complex in a heterologous system, and few methods exist to purify sufficient protein from a native source for use in biochemical, biophysical and structural studies. Here, we provide a detailed protocol for the isolation of membrane protein complexes from transgenic Caenorhabditis elegans. We describe how to grow a genetically modified C. elegans line in abundance using standard laboratory equipment, and how to optimize purification conditions on a small scale using fluorescence-detection size-exclusion chromatography. Optimized conditions can then be applied to a large-scale preparation, enabling the purification of adequate quantities of a target protein for structural, biochemical and biophysical studies. Large-scale worm growth can be accomplished in ~9 d, and each optimization experiment can be completed in less than 1 d. We have used these methods to isolate the transmembrane channel-like protein 1 complex, as well as three additional protein complexes (transmembrane-like channel 2, lipid transfer protein and 'Protein S'), from transgenic C. elegans, demonstrating the utility of this approach in purifying challenging, low-abundance membrane protein complexes.

Indexed as

Caenorhabditis elegansCaenorhabditis elegans ProteinsAnimalsAnimals, Genetically ModifiedCell LineChromatography, GelMembrane ProteinsCaenorhabditis elegans ProteinsMembrane Proteins

Identifiers

PMID37495753
PMCPMC13012274
OpenAlexW4385270938

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.